Bluemoor Health reports quarterly revenue above the internal plan
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
Bluemoor Health
Healthcare · Medical Devices
Updated UTC
146,21 $US
+1,91+1,32 %
After hours145,56 $US-0,44 %
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 12,63 Md | 14,13 Md | 15,19 Md | 15,96 Md | 17,26 Md |
| Gross profit | 7,23 Md | 8,43 Md | 8,68 Md | 9,28 Md | 10,31 Md |
| Operating income | 2,62 Md | 3,12 Md | 3,2 Md | 2,99 Md | 3,14 Md |
| Net income | 1,87 Md | 1,82 Md | 2,38 Md | 2,03 Md | 2,49 Md |
Develops remote-monitoring hardware and clinical software for chronic-care providers.
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
The company approved a multi-year capital program intended to shorten lead times for its largest customers.
Market Wire
A sell-side desk kept a neutral rating while noting that near-term estimates already reflect steady execution.
Sector Desk
The board named an internal candidate with prior treasury and investor-relations experience to the role.
Market Wire
The authorization covers a modest slice of the float and will be funded from operating cash flow.
Market Wire